CVS Caremark to buy Coram for $2.1 billion
http://finance.yahoo.com/news/cvs-caremark-buy-coram-2-143453305.html
Just wait until CVS/Caremark uses their “efficiency formula” on the home IV business…
There is more profits in “high risk non-sterile to sterile compounding” Remember the NECC fiasco ?
Luckily a lot of this business is private pay and Medicare Part B.. and CVS/Caremark doesn’t administer those programs…may be a while before we see restricted networks for those products .. but then we don’t know what Obamacare is going to shove down our throats or up our asses !
Filed under: General Problems
Leave a Reply